Sarepta Therapeutics, Inc. stock price

Sarepta Therapeutics, Inc. latest news:


  • 07/19/2017 15:29:24

    Sarepta shoots higher as sales of $300,000-a-year drug exceed expectations

    Sarepta Therapeutics Inc. shares shot more than 13% higher in late trading Wednesday after the company reported sales of its $300,000-a-year drug for Duchenne muscular dystrophy were better than expected. Sarepta announced second-quarter revenue of $35 million, easily beating the average analyst forecast of $22.5 million, according to a FactSet survey. The company underwent a nearly decade-long effort to get FDA approval for eteplirsen, the first approved treatment for DMD. Sarepta also increased its forecast for full-year revenue, to a range of $125 million to $130 million from previous guidance of more than $95 million. Sarepta stock rose to about $38.80 in late trading, after closing with a 0.6% gain at $34.08; the stock is up more than 61% in the past year, as the S&P 500 index has gained 13.7%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 06/28/2017 16:58:14

    Sarepta Therapeutics names new CEO

    Drugmaker Sarepta Therapeutics Inc. on Wednesday named Douglas Ingram its next chief executive. Ingram, currently the president and CEO at Allergan PLC's Chase Pharmaceutics, will start Sept. 20, Sarepta said. He replaces Edward Kaye, who took over as interim chief executive in 2015. Last year, Sarepta won government approval for its Duchenne muscular dystrophy drug.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    SB Financial Group, Inc.SBFG | SB Financial Group, Inc.SBFGP | SBA Communications CorporationSBAC | ScanSource, Inc.SCSC | Schmitt Industries, Inc.SMIT | Schnitzer Steel Industries, Inc.SCHN | Scholastic CorporationSCHL | SciClone Pharmaceuticals, Inc.SCLN | Scientific Games CorpSGMS | SciQuest, Inc.SQI |